Trial Profile
Effects of Pre-operative Pregabalin and Ketamine to Prevent Development of Phantom Pain in Patients Undergoing Lower Extremity Amputation
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 21 Dec 2018
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Ketamine
- Indications Phantom limb pain
- Focus Therapeutic Use
- 24 Apr 2018 Planned End Date changed from 1 Aug 2017 to 20 Sep 2017.
- 24 Apr 2018 Planned primary completion date changed from 1 apr 2017 to 20 May 2016.
- 24 Apr 2018 Status changed from recruiting to withdrawn prior to enrolment.